2023 U.S.-Booked Air Volume: $27.9 million 
Consolidated U.S. TMC: CWT

The U.S.-booked air travel spend of Edwards Lifesciences increased marginally in 2023, to $27.9 million, according to BTN estimates. 

Revenue increased from $5.4 billion in 2022 to $6 billion in 2023 with 58 percent of sales within the U.S. The company employed around 19,800 people at the end of 2023, the majority of whom were located in the U.S., Singapore, Dominican Republic and Costa Rica. 

The company made a significant investment in R&D spending last year, up 13 percent, which may have contributed to a jump in the company’s business travel activity and associated emissions. That figure was 54,314 metric tons of CO2e (9 percent of overall emissions), up from 41,377 in 2022, although the company noted a change in the way it calculated GHG emissions in 2023. 

Bernard Zovighian took over as CEO of the company in May 2023 from Michael A. Mussalem following his retirement.